1-4 of 4
Pilar Herrera, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Correlation Clinical Responses to 1 st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test

Pau Montesinos, MD, Joan Ballesteros, David Martínez-Cuadrón, Joaquín Martínez-López, Josefina Serrano, Jaime Perez de Oteyza, Pascual Fernández, Gabriela Rodriguez-Macías, Mª Belén Vidriales, Pilar Herrera, MD PhD, Mar Tormo, MD PhD, Juan Bergua, Raimundo García, MD, Susana Vives, Mª Ángeles Fernández, Esperanza Lavilla, MD, Santiago Jimenez, Jose Antonio Pérez-Simón, Adriana Simiele, Ataulfo González, Bernardo J. González, Carmen Burgaleta, Juan Antonio López, Concepción Bethancourt, Guiomar Bautista, Arancha Alonso, Mercedes Colorado, Jordi Sierra, Begoña Navas, José Angel Hernández-Rivas, Juan Antonio Vera, Mª Lourdes Amador, Raúl Cordoba, MD, Adolfo de la Fuente, Fernando Ramos, MD PhD MPH, Carlos Javier Cerveró, Consolación Rayón, Olga Salamero, Edelmira Martí, Aurelio López, Teresa Olavé, Marta Gaspar, Julian Gorrochategui, José Luis Rojas, Cristina Gomez, Pilar Hernández, Alicia Robles, Ignacio Ortega, Jesús Villoria, Federico Moscardó, Iñaki Troconiz, Miguel A. Sanz, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4837.
https://doi.org/10.1182/blood.V126.23.4837.4837
Published: 2015
Journal Articles

A Way to Individualized Therapy in Acute Myeloid Leukemia (AML): NGS Mutational Profile and Ex Vivo Pharmacological Test (Ex-viTech)

Esther Onecha, Joan Ballesteros, Jose L Rojas, Jose M Sanchez, Eva Barragan, PhD, Inmaculada Rapado, PhD, Santiago Barrio, David Martinez, MD PhD, Pau Montesinos, MD, Pilar Herrera, MD PhD, Carmen Burgaleta, MD, Joaquin Martinez-López, MDPhD, Rosa M. Ayala, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1376.
https://doi.org/10.1182/blood.V126.23.1376.1376
Published: 2015
Journal Articles

Initial Results of the Phase I/II Panobidara Study of Panobinostat in Combination with Idarubicin and Cytarabine in Patients Aged 65 Years or Older with Newly Diagnosed Acute Myeloblastic Leukaemia (AML)

Enrique M Ocio, MD, PhD, Pilar Herrera, MD, PhD, Teresa Olave, MD, Salut Brunet, Albert Oriol, Maria-Pilar Martínez-Sánchez, Miguel A. Sanz, MD, PhD, Marta Mateos, MD, Pilar Aliseda, MD, Ivo J. Winiger, MD, Sushant Hardikar, Maria Victoria Mateos, MD, PhD, Javier Lopez, Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1512.
https://doi.org/10.1182/blood.V120.21.1512.1512
Published: 2012
Journal Articles

Impact of Second-Generation Tyrosine Kinase Inhibitors As Second Line Treatment for Patients with Chronic Myeloid Leukemia,

J Valentin Garcia-Gutierrez, MD, PhD, Pilar Herrera, MD, PhD, Lorena L Abalo, Maria Dolores Rey, Maria Calbacho, Lourdes Ramos, Paloma Ramos, Carlos Montalban, MD, PhD, Javier Lopez-Jimenez, MD
Journal: Blood
Blood (2011) 118 (21): 3780.
https://doi.org/10.1182/blood.V118.21.3780.3780
Published: 2011